Cumberland Pharmaceuticals
49 clinical trials · Sponsor
◉ Watch Cumberland Pharmaceuticals
| Record | Firm | Date |
|---|---|---|
| Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF) (NCT05571059) | Cumberland Pharmaceuticals | 2024-01-31 |
| Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy (NCT03340675) | Cumberland Pharmaceuticals | 2020-10-19 |
| Dose-ranging Efficacy and Pharmacokinetics Study of Intravenous Atorvastatin in Hypercholesterolemic Patients (NCT03611010) | Cumberland Pharmaceuticals | 2018-08-07 |
Track Cumberland Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.